Equities Research Analysts’ Updated EPS Estimates for June 9th (AAL, AAPL, ANTO, AZN, BATS, BCDA, BHP, BRC, BTA, CLF)

Equities Research Analysts’ updated eps estimates for Tuesday, June 9th:

Anglo American (LON:AAL) had its buy rating reissued by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a GBX 5,000 target price on the stock.

Apple (NASDAQ:AAPL) had its hold rating reissued by analysts at Needham & Company LLC.

Apple (NASDAQ:AAPL) had its neutral rating reiterated by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $276.00 target price on the stock.

Antofagasta (LON:ANTO) had its hold rating reiterated by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 4,500 price target on the stock.

AstraZeneca (LON:AZN) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a £180 price target on the stock.

Astrazeneca (NYSE:AZN) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc..

Astrazeneca (NYSE:AZN) had its buy rating reiterated by analysts at JPMorgan Chase & Co..

Astrazeneca (NYSE:AZN) had its sell rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.

British American Tobacco (LON:BATS) had its buy rating reiterated by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 5,200 price target on the stock.

BioCardia (NASDAQ:BCDA) had its buy rating reissued by analysts at HC Wainwright. They currently have a $25.00 price target on the stock.

BHP Group (LON:BHP) had its hold rating reaffirmed by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a GBX 3,600 price target on the stock.

Brady (NYSE:BRC) was upgraded by analysts at Sidoti from a neutral rating to a buy rating. The firm currently has $103.00 price target on the stock.

BlackRock Long-Term Municipal Advantage Trust’s (LON:BTA) had its sell rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 150 price target on the stock.

Cleveland-Cliffs (NYSE:CLF) was upgraded by analysts at Glj Research from a sell rating to a hold rating. The firm currently has $15.01 target price on the stock, up from their previous target price of $9.03.

Costain Group (LON:COST) had its buy rating reiterated by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 240 price target on the stock.

eToro Group (NASDAQ:ETOR) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a $65.00 price target on the stock.

Evolv Technologies (NASDAQ:EVLV) had its buy rating reaffirmed by analysts at TD Cowen. TD Cowen currently has a $10.00 target price on the stock.

Expedia Group (NASDAQ:EXPE) had its buy rating reissued by analysts at BTIG Research. The firm currently has a $330.00 price target on the stock.

Fevertree Drinks (LON:FEVR) had its buy rating reissued by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a GBX 1,080 target price on the stock.

Fair Isaac (NYSE:FICO) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $1,650.00 price target on the stock.

Glencore (LON:GLEN) had its buy rating reissued by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a GBX 720 target price on the stock.

The Gym Group (LON:GYM) had its buy rating reiterated by analysts at Deutsche Bank Aktiengesellschaft. Deutsche Bank Aktiengesellschaft currently has a GBX 230 price target on the stock.

Halfords Group (LON:HFD) had its buy rating reissued by analysts at Shore Capital Group Ltd.

Invivyd (NASDAQ:IVVD) had its buy rating reissued by analysts at BTIG Research. BTIG Research currently has a $10.00 target price on the stock.

Lennar (NYSE:LEN) was downgraded by analysts at Keefe, Bruyette & Woods from a market perform rating to an underperform rating. They currently have $86.00 price target on the stock, down from their previous price target of $97.00.

Lumentum (NASDAQ:LITE) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $1,040.00 target price on the stock.

Lyell Immunopharma (NASDAQ:LYEL) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $45.00 target price on the stock.

MoonLake Immunotherapeutics (NASDAQ:MLTX) had its buy rating reissued by analysts at BTIG Research. BTIG Research currently has a $30.00 price target on the stock.

Neurogene (NASDAQ:NGNE) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $70.00 target price on the stock.

Nuvalent (NASDAQ:NUVL) was downgraded by analysts at HC Wainwright from a buy rating to a neutral rating. The firm currently has $124.00 price target on the stock.

Nuvalent (NASDAQ:NUVL) was downgraded by analysts at Wedbush from an outperform rating to a neutral rating. Wedbush currently has $124.00 target price on the stock, down from their previous target price of $125.00.

Nuvalent (NASDAQ:NUVL) had its market perform rating reaffirmed by analysts at Lifesci Capital. Lifesci Capital currently has a $124.00 target price on the stock.

On the Beach Group (LON:OTB) was upgraded by analysts at Shore Capital Group Ltd to a buy rating. Shore Capital Group Ltd currently has GBX 210 target price on the stock.

PAR Technology (NYSE:PAR) was upgraded by analysts at JPMorgan Chase & Co. from an underweight rating to a neutral rating. They currently have $16.00 target price on the stock, up from their previous target price of $12.00.

Prudential Financial (NYSE:PRU) was downgraded by analysts at Argus from a buy rating to a hold rating.

Rio Tinto Group (LON:RIO) had its hold rating reaffirmed by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 8,500 target price on the stock.

Cartesian Therapeutics (NASDAQ:RNAC) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $40.00 target price on the stock.

Cartesian Therapeutics (NASDAQ:RNAC) had its buy rating reissued by analysts at BTIG Research. They currently have a $44.00 target price on the stock.

South32 (LON:S32) had its buy rating reissued by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 300 target price on the stock.

SailPoint (NASDAQ:SAIL) had its buy rating reaffirmed by analysts at BTIG Research. BTIG Research currently has a $18.00 price target on the stock.

Toll Brothers (NYSE:TOL) was upgraded by analysts at Keefe, Bruyette & Woods from a market perform rating to an outperform rating. The firm currently has $161.00 price target on the stock, up from their previous price target of $158.00.

Tesco (LON:TSCO) had its buy rating reiterated by analysts at Deutsche Bank Aktiengesellschaft. The firm currently has a GBX 525 price target on the stock.

VinFast Auto (NASDAQ:VFS) had its buy rating reaffirmed by analysts at Chardan Capital. The firm currently has a $5.50 target price on the stock.

WPP (LON:WPP) had its buy rating reiterated by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 405 target price on the stock.

Zevra Therapeutics (NASDAQ:ZVRA) had its buy rating reaffirmed by analysts at BTIG Research. They currently have a $27.00 price target on the stock, up from their previous price target of $23.00.